ArticleThe Journal of clinical investigation2013

Efficacious proteasome/HDAC inhibitor combination therapy for primary effusion lymphoma.

Shruti Bhatt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.